Guru Fundamental Report for JNJ

Validea's analysis rates Johnson & Johnson (JNJ) at 85% using the Meb Faber Shareholder Yield Investor model, which identifies companies returning cash to shareholders via dividends, buybacks, and debt paydown. This high rating, indicating significant interest for a large-cap growth stock in the Biotechnology & Drugs sector, suggests JNJ aligns well with strategies focused on robust shareholder returns.

Analysis

Johnson & Johnson (JNJ) has been rated favorably at 85% by Validea's Shareholder Yield Investor model, a strategy developed by Meb Faber that prioritizes companies actively returning cash to shareholders. As a large-cap growth stock within the Biotechnology & Drugs sector, this high score indicates significant alignment with the model's criteria, which focus on dividends, share buybacks, and debt reduction. The analysis reveals that JNJ successfully passes key tests for Net Payout Yield, Quality and Debt, Valuation, and Relative Strength, underscoring its solid fundamentals. However, it is notable that despite the high overall score and the model's focus, JNJ specifically fails the 'Shareholder Yield' criterion. This nuanced result suggests that while the company performs well on individual components of capital return and quality, its composite shareholder yield metric, as calculated by this specific model, does not meet the required threshold.

Key Decisions for Investors

• Investors with a strategy focused on capital returns should consider the 85% rating a positive signal, supported by JNJ's passing scores on net payout yield, quality, and valuation.
• It is prudent to conduct further due diligence into why JNJ failed the specific 'Shareholder Yield' test to fully understand the composition and magnitude of its capital return program relative to the model's strict definition.
• For those seeking a defensive holding, JNJ's positive rating on a shareholder return model, combined with its large-cap status in the healthcare sector, suggests a potentially attractive blend of stability and shareholder-focused value creation.